AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Biohit Oyj

Board/Management Information • Jul 5, 2016

3304_iss_2016-07-05_920b7e55-e557-4d14-b87c-741f2b038fc4.html

Board/Management Information

Open in Viewer

Opens in native device viewer

Disclosure 343864

Biohit Oyj - Changes board/management/auditors

Changes to Biohit Oyj’s Management Team

Biohit Oyj Stock Exchange Release July 5, 2016 at 09:30 a.m. local time (EEST) M.Sc. (Tech.), Daniela Söderström (b. 1987) has been appointed as Quality and Regulatory Affairs Director and a member of the Management Team of Biohit Oyj as of July 5, 2016. She joined Biohit Oyj in 2014. In her new position she reports to CEO Semi Korpela. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com